NEW YORK, Nov. 08, 2016 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX), an oncology company developing innovative medicines and other products for targeting and treating cancer, today announced that Mark Baker, Chief Executive Officer, will present at two upcoming investor conferences:
- Presentation at the Stifel 2016 Healthcare Conference on Tuesday, November 15, 2016 at 3:45 p.m. Eastern Time. The conference is being held at the Lotte New York Palace Hotel in New York City.
- Presentation at the Jefferies London Healthcare Conference on Thursday, November 17, 2016 at 9:20 a.m. Greenwich Mean Time. The conference is being held at the Waldorf Hilton in London, UK.
Contact:Melissa DownsInvestor Relations(646) email@example.com